Hilary Wicai | Feb 17, 2006
The world's largest cereal maker turns 100 this weekend, and as Hillary Wicai reports, it might need to change its ingredients if it wants to stay on top.
| Feb 17, 2006
This installment of the Job Files looks at Wurlitzer organ player Jim Riggs.
Helen Palmer | Feb 17, 2006
A free-market think tank north of the border warns that the land of the maple leaf could face a prescription drug shortage, given the amount of Canadian medicines sold to Americans over the Internet. Helen Palmer reports.
Sarah Gardner | Feb 17, 2006
The Golden State plans to limit carbon emissions from private utilities and open a carbon market where companies can buy and sell carbon credits. As Sarah Gardner reports, California is the largest in a growing number of states experimenting with cap-and-trade.
Stephen Beard | Feb 17, 2006
A possible mega-merger in the steel industry has scared French regulators. It would not only create a company with more than 10% of the world's market; it would also put at risk thousands of French jobs. So the government is looking for new ways to ward off takeover bids from abroad.From London, Stephen Beard reports.
Dan Grech | Feb 17, 2006
$365 million is the jackpot for this Saturday's Powerball lottery. It's the largest in US history. The number's got us thinking... $365 million. A million bucks a day for a year. What could you buy for that kind of money? Dan Grech dreams about a lottery payday.
Bob Moon | Feb 16, 2006
Today, XM Satellite Radio execs were playing up all the new subscribers they signed up last year. But it turns out XM paid dearly for all those ears: It posted a loss of almost $270 million for the final quarter of 2005. Bob Moon reports.
Alisa Roth | Feb 16, 2006
Tomorrow could be a big day for GM. That's when auto parts supplier Delphi decides if it'll ask a judge to void its union contracts. Delphi workers have threatened to strike if that happens, and that could shut down General Motors plants, which depend on Delphi for parts. Alisa Roth has more.
Helen Palmer | Feb 16, 2006
One of Silicon Valley's biggest venture capital firms will invest $200 million into a pandemic and bio-defense fund. The VC fund also invested in Google and Amazon. Helen Palmer looks into whether its latest idea has legs.
| Feb 16, 2006
Genentech's drug Avastin is a highly effective treatment for colon, breast, and lung cancer. It's also incredibly expensive. Genentech says society has to be willing to pay more for the benefits of life-sustaining drugs, but Commentator Jamie Court says drug companies have a moral obligation not to price them out of reach.